Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar:122:108214.
doi: 10.1016/j.jsat.2020.108214. Epub 2020 Nov 24.

Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19

Max Jordan Nguemeni Tiako  1
Affiliations

Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19

Max Jordan Nguemeni Tiako. J Subst Abuse Treat. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Andraka-Christou B., Capone M.J. A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices. International Journal of Drug Policy. 2018;54:9–17. doi: 10.1016/j.drugpo.2017.11.021. - DOI - PubMed
    1. Andraka-Christou B., Gabriel M., Madeira J., Silverman R.D. Court personnel attitudes towards medication-assisted treatment: A state-wide survey. Journal of Substance Abuse Treatment. 2019;104:72–82. doi: 10.1016/j.jsat.2019.06.011. - DOI - PubMed
    1. Bourgois P. Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry. 2000;24(2):165–195. doi: 10.1023/A:1005574918294. - DOI - PubMed
    1. Carlson R.G., Daniulaityte R., Silverstein S.M., Nahhas R.W., Martins S.S. Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose? International Journal of Drug Policy. 2020;79:102722. doi: 10.1016/j.drugpo.2020.102722. - DOI - PMC - PubMed
    1. Davis C.S., Samuels E.A. Opioid policy changes during the COVID-19 pandemic - and beyond. Journal of Addiction Medicine. 2020;14(4) doi: 10.1097/ADM.0000000000000679. - DOI - PMC - PubMed